Katie Hasson

Katie Hasson, PhD, writes, speaks, researches, and teaches about the social and political aspects of human genetic and reproductive technologies. Katie earned her PhD in Sociology with a Designated Emphasis in Women, Gender, and Sexuality from the University of California, Berkeley, and was previously Assistant Professor of Sociology and Gender Studies at the University of Southern California.

Profile picture for user Katie Hasson

Publications

CRISPR
By Katie Hasson and Marcy Darnovsky, The Hill | 09.13.2020

In November 2018, at a gene-editing “summit” hosted by scientific societies from the U.S., the U.K., and Hong...

Vertical lines of diffuse blue lights on a dark background
By Donna Dickenson, Katie Hasson & Marcy Darnovsky, Project Syndicate | 03.17.2020

The announcement by the Chinese biophysicist He Jiankui in November 2018 that he had created the world’s first gene-edited babies...

Global with DNA letter around it
By Roberto Andorno, Françoise Baylis, Marcy Darnovsky, Donna Dickenson, Hille Haker, Katie Hasson, Leah Lowthorp, et al., Trends in Biotechnology | 01.31.2020

Heritable Human Genome Editing: Nearing a Critical Juncture

The impending decision about whether to develop and use heritable human genome...

In the News

Gene editing and scientist
By Hannah Devlin, Tom Burgis, David Pegg, and Jason Wilson, The Guardian [cites CGS’ Katie Hasson] | 10.18.2024

A US startup company is offering to help wealthy couples screen their embryos for IQ using controversial technology that raises...

dna strands on a green background
By Ashleigh Wyss [cites CGS' Katie Hasson], Listnr | 10.09.2024

Discovering your genetic history can be as simple as spitting into a test tube, but what happens when your data...

a graphic of a "superbaby"
By Julia Black and Margaux MacColl, The Information [cites CGS' Katie Hasson] | 07.19.2024

When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they...

Biopolitical Times

This week in London, some 400 people from around the world – including scientists, bioethicists, patients, journalists, civil society groups...

 Rehua, CC BY-SA 3.0, via Wikimedia Commons

James Wilson, director of the Gene Therapy Program at Penn’s...